| Literature DB >> 25536488 |
Qian Liu1, Kaiyue Wu2, Yongbo Cheng1, Lei Lu1, Erting Xiao1, Yuchen Zhang1, Zixin Deng1, Tiangang Liu3.
Abstract
Alkanes and alkenes are ideal biofuels, due to their high energy content and ability to be safely transported. To date, fatty acid-derived pathways for alkane and alkene bioproduction have been thoroughly explored. In this study, we engineered the pathway of the iterative Type I polyketide synthase (PKS) SgcE with the cognate thioesterase (TE) SgcE10 in Escherichia coli, with the goal of overproducing pentadecaheptaene (PDH) followed by its hydrogenation to pentadecane (PD). Based on initial in vitro titration assays, we learned that PDH production is strongly dependent on the SgcE10:SgcE ratio. Thus, we engineered a high-yield E. coli strain by fine-tuning SgcE10 expression via synthetic promoters. We analyzed engineered E. coli strains using a modified multiple reactions monitoring mass spectrometry (MRM-MS)-based targeted proteomic approach, using a chimeric SgcE10 and SgcE fusion construct to gain insight into expression levels of the two proteins. Lastly, through fed-batch fermentation followed by flow chemical hydrogenation, we obtained a PD yield of nearly 140mg/L in single-alkane form. Thus, we not only employed a metabolic engineering approach to the iterative polyketide pathway, we highlighted the potential of PKS shunt products to play a role in the production of single-form and high-value chemicals.Entities:
Keywords: Alkane; Alkene; Iterative Pks; Precise protein regulation; Targeted engineering; Thioesterases; in vitro reconstitution
Mesh:
Substances:
Year: 2014 PMID: 25536488 DOI: 10.1016/j.ymben.2014.12.004
Source DB: PubMed Journal: Metab Eng ISSN: 1096-7176 Impact factor: 9.783